Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PADIT: Incremental vs Conventional Antibiotics for CIED Infection Prevention
NCT01628666Phase 4Completed
- Sponsor
- Population Health Research Institute
- Start
- Dec 2012
- Primary completion
- Sep 2017
- Modality
- Reversible Covalent Inhibitors, Cyclic Peptides, Antimicrobial Peptides
- Countries
- 1
01
Overview
A Phase 4 trial of cefazolin, vancomycin, bacitracin, cefalexin in cardiac implantable electronic device infection (CIEDI), sponsored by Population Health Research Institute. Started Dec 2012; status: completed.
02
Drugs
cefazolinvancomycinbacitracincefalexin
03
Conditions
cardiac implantable electronic device infection (CIEDI)
Beyond the preview
Go deeper on NCT01628666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01628666.